Eleonora Teplinsky, MD
@drteplinsky
Followers
4K
Following
7K
Media
477
Statuses
5K
Breast & gyn med onc @valleyhealthnj. Opinions my own. Host of INTERLUDE podcast. đź“— BEYOND THE PINK (2026). Patient education on Instagram.
New Jersey, USA
Joined December 2017
Proud of our work highlighting real world sexual health experiences of women with breast cancer. It’s a significant issue and many are not getting the treatment and information they need and deserve! #bcsm @LailaAgrawalMD.
Women’s Insights on Sexual Health After #BreastCancer.(WISH-BREAST) Survey. Authored by @LailaAgrawalMD, @drteplinsky, et al. #bcsm. Read full article.
1
6
15
RT @LailaAgrawalMD: Thank you @JCOOP_ASCO for highlighting our WISH-BREAST study on sexual health after breast cancer. 🙏 Please read the p….
0
1
0
RT @NazliDizman: 🙋‍♀️Hello!! How's your schedule this fall? .🌟#WomenInOncology, save Sep 27-28 for #LEAD25!.It's a fantastic opportunity fo….
0
17
0
RT @PTarantinoMD: After saying goodbye to anthracyclines— are we ready to also drop the carbo for our patients with stage II HER2+ breast c….
0
17
0
You are incredible @ipreeshagul đź©·.
SURREAL sharing my experience caring for others at the @MSKCME #oncologytoxicitysymposium .Fun fact✔️My very first meeting @MSKCancerCenter as a college student I sat in the audience here , watching my mom’s oncologist speak. Being up here amongst these trailblazers is full â•ď¸Ź 🥹
1
1
4
RT @drsarahsam: A nice patient friendly article on how metastases occur in breast cancer and how cells adapt to their metastatic environmen….
0
47
0
RT @BioAscend: #LEAD2025 is taking place on September 26-27 in Scottsdale, AZ! The goal of this conference is to empower women leaders in t….
0
1
0
RT @nlinmd: What happens when you query chatGPT with 362 breast cancer cases?. -46% responses differed from breast cancer expert opinion. -….
0
43
0
RT @SurvivorNetTeam: Exciting updates from #ASCO25 in today’s newsletter. • Breast cancer survivors open up about life after treatment.• T….
0
2
0
Thank you for the opportunity to contribute to the Ed Book! A fantastic experience! #ASCO25.
There really are no words for how grateful I am for this experience. Thank you to @ASCO and Ed Book staff Krystal and Meagan, to AEs @hoperugo and @PBarataMD, and to Don Dizon who mentored me in this role. And of course to our authors and readers who made Ed Book a success!
1
1
14
RT @ASCO: Want to share practice-changing research from #ASCO25 with your patients? 18 summaries highlighting key studies in #BreastCancer,….
0
18
0
RT @CCortiMD: Pleased to share the first series of pts who experienced recurrence on adjuvant abemaciclib+ET:. ➤ 9.2% (15/163) recurred.➤ 5….
0
34
0
RT @ShannonWestin: Phase 2 study of lenvatinib and pembrolizumb is active in clear cell #ovariancancer !!! . 👍 36.7% response rate .🙌 PFS 1….
0
10
0
RT @SurvivorNetTeam: Catch ASCO Day 1 highlights from @DrTeplinsky, who moderated our Breast Cancer panel in Chicago. Stay tuned — the ful….
0
1
0
RT @VivekSubbiah: 🚨 Wow! #ASCO25 @ASCO was absolutely massive!.10 @NEJM papers published simultaneously 👉 all practice-changing studies !….
0
183
0
RT @fumikochino: Oncologists are “losing the battle” against misinformation. @thetimes on #ASCO25 research presented @ASCO including our w….
0
28
0
RT @DrBetofMDPhD: I’ve been in the exercise oncology field for 20 years and for all of that time, the main criticism has been “show me a we….
0
64
0
RT @OncBrothers: 7. Time of the Day for IO: Ph III, Early (before 3:00PM) vs Late(after 3:00PM), lung ca, 🇨🇳 only. - mOS NR vs 16.4mos (HR….
0
3
0
RT @OncBrothers: 2. #SOFT/TEXT: AI + Ovarian Function Suppression vs. Tamox in Premenopausal. - DFS in T+OFS vs T, HR 0.85! BCFI benefit wa….
0
1
0